RE:RE:Takeda acquiring Nimbus Therapeutics subsid for US$4 BillionYou can use Pela with coconut milk too Noteable, but to administer it to patients and make money from sales, you do realise you need a marketing authorisation, you do realise that right ?
So, for all the combos you mention, all of which will require (for US at least) two randomised trials... WHO will be paying for all that..? It seems all ONCY ever does is start yet more trials, never quite having enough data to prove if it's worth pursuing or not... clever strategy...
LOL...
Phase II mBC trial started in 2012, so to get us through Phase III and to Approval will have taken 14 years (that's of course if we'd started this summer... ) so now its more like 15 years...
The first Crispr CAS-9 dossier is on a rolling submission already with FDA. It could be approved by end of Q2 2023... and that will just open the floodgates... Like I say, time is ticking...